Entering text into the input field will update the search result below

Lexaria shares up 15% premarket on CBD blood pressure study results

Sep. 07, 2021 8:27 AM ETLEXXBy: Jonathan Block, SA News Editor6 Comments

Blood pressure monitor indicates low blood pressure
Ralf Geithe/iStock via Getty Images

  • Patients with mild to moderate hypertension saw their blood pressure decrease as much as 23% compared to placebo after taking Lexaria Bioscience's (LEXX) DehydraTECH-processed cannabidiol.
  • The company released partial results today, with additional data analyses

Recommended For You